TY - CHAP
T1 - Pharmacometabolomics: A New Horizon in Personalized Medicine
AU - Emwas, AbdulHamid
AU - Szczepski, Kacper
AU - T. McKay, Ryan
AU - Asfour, Hiba
AU - Chang, Chungke
AU - Lachowicz, Joanna
AU - Jaremko, Mariusz
N1 - KAUST Repository Item: Exported on 2021-10-02
Acknowledgements: We would like to thank King Abdullah University of Science and Technology (KAUST) for financial support.
PY - 2021/8/9
Y1 - 2021/8/9
N2 - Pharmacology is the predominant first-line treatment for most pathologies. However, various factors, such as genetics, gender, diet, and health status, significantly influence the efficacy of drugs in different patients, sometimes with fatal consequences. Personalized diagnosis substantially improves treatment efficacy but requires a more comprehensive process for health assessment. Pharmacometabolomics combines metabolomic, genomic, transcriptomic and proteomic approaches and therefore offers data that other analytical methods cannot provide. In this way, pharmacometabolomics more accurately guides medical professionals in predicting an individual’s response to selected drugs. In this chapter, we discuss the potentials and the advantages of metabolomics approaches for designing innovative and personalized drug treatments.
AB - Pharmacology is the predominant first-line treatment for most pathologies. However, various factors, such as genetics, gender, diet, and health status, significantly influence the efficacy of drugs in different patients, sometimes with fatal consequences. Personalized diagnosis substantially improves treatment efficacy but requires a more comprehensive process for health assessment. Pharmacometabolomics combines metabolomic, genomic, transcriptomic and proteomic approaches and therefore offers data that other analytical methods cannot provide. In this way, pharmacometabolomics more accurately guides medical professionals in predicting an individual’s response to selected drugs. In this chapter, we discuss the potentials and the advantages of metabolomics approaches for designing innovative and personalized drug treatments.
UR - http://hdl.handle.net/10754/670601
UR - https://www.intechopen.com/online-first/77592
U2 - 10.5772/intechopen.98911
DO - 10.5772/intechopen.98911
M3 - Chapter
BT - Metabolomics - Methodology and Applications in Medical Sciences and Life Sciences
PB - IntechOpen
ER -